Navigation Links
The genomics symposium to boost the further development of cancer research
Date:7/3/2012

July 3, 2012, London, United Kingdom, and Shenzhen, China The symposium themed "The Era of Next Generation Sequencing in Cancer", co-organized by BGI, the world's largest genomics organization, and Imperial College London, was successfully conducted in London, UK. Around 70 experts, scholars, and representatives from the local colleges, institutes and biotechnology industries attended the meeting with the aim to exchange their insights on high-throughput genomics and accelerate the further development of cancer research.

The symposium started with a friendly opening remark by Professor Charles Coombes, Director of Division of Cancer, Imperial College, and Hon Consultant Medical Oncologist, Imperial College Healthcare Trust. He was delighted to be the chairman of the symposium, and said:" The symposium is a good start between Imperial College London and BGI. We are looking forward to more collaboration with BGI, one of the largest genomics organizations in the world. We are confident that we will make more breakthroughs together in the near future."

After that, experts delivered several excellent presentations highlighting the advancements in cancer research, including "Cancer genome research in BGI", "Understanding estrogen receptor transcription in breast cancer", "Genetic analysis of five cancers using single-cell sequencing", "Genetic regulation of the rat cardiac methylome", "Personalized epigenetic therapy in follicular lymphoma", "Biomarker discovery through integrated next-generation sequencing (NGS) genomic analysis of neuroendocrine tumors", among others.

Yingrui Li, Vice Director of BGI, shared several case studies on cancer genome research applying BGI's NGS and bioinformatics technologies. He referred that the object of their studies is to make more contributions in cancer research and boost the transformation of scientific discoveries to benefit human health. He emphasized that, "NGS technologies, especially single-cell sequencing technology, elevate cancer research to a new level, enabling researchers to conduct cancer studies for the treatment and diagnosis of cancer at the cellular level and whole-genome level."

Cancer genome research has been one of the most important fields in life science. With the rapid development of the NGS technologies, it allows researchers to comprehensively explore the characteristics underlying cancers. The symposium brought together leading scientists and researchers from UK and China, providing a truly international platform for strengthening the academic cooperation and communication between the two countries.


'/>"/>

Contact: Jia Liu
liujia@genomics.cn
BGI Shenzhen
Source:Eurekalert

Related biology news :

1. SDSCs big data expertise aiding genomics research
2. BGI, University of Helsinki and Wuhan University sign a MOU concerning cooperation on genomics
3. In search for a vaccine, IU biologist receives $2.3 million to explore chlamydia genomics
4. ACRG and BGI report findings from genomics research on recurrent hepatitis B virus integration
5. 5th Annual Advances in Biomolecular Engineering Symposium
6. Science, Innovation, and Partnerships for Sustainability -- Symposium May 16-18
7. Coral reef experts to present latest coral reef science during July symposium
8. FirstMark Exhibiting and Presenting at the San Diego Academy of Family Physicians 55th Annual Postgraduate Symposium
9. Topics to be discussed during July International Coral Reef Symposium
10. MARC Travel Awards announced for the 26th Annual Symposium of the Protein Society
11. New method for estimating parameters may boost biological models
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/11/2017)... , April 11, 2017 Crossmatch®, ... secure authentication solutions, today announced that it has ... Advanced Research Projects Activity (IARPA) to develop next-generation ... program. "Innovation has been a driving ... Thor program will allow us to innovate and ...
(Date:4/6/2017)... -- Forecasts by Product Type (EAC), Biometrics, ... (Transportation & Logistics, Government & Public Sector, Utilities / ... Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality ... looking for a definitive report on the $27.9bn Access ... ...
(Date:4/4/2017)... April 4, 2017   EyeLock LLC , a ... the United States Patent and Trademark Office (USPTO) has ... the linking of an iris image with a face ... represents the company,s 45 th issued patent. ... very timely given the multi-modal biometric capabilities that have ...
Breaking Biology News(10 mins):
(Date:5/22/2017)... (PRWEB) , ... May 22, 2017 , ... ... today that it is exhibiting in booth B2 at the Association for ... May 22-25. , In addition to demonstrating its Cancer Diagnostic Cockpit and ...
(Date:5/18/2017)... ... May 18, 2017 , ... ... April 28, 2017 at the Prince Of Wales Private Hospital. The procedure was ... level C6-C7. The patient failed conservative treatments prior to undergoing surgery. , The ...
(Date:5/18/2017)... ... May 17, 2017 , ... ... compliance and commercialization, has just released version 9.0 of the Cognition Cockpit platform. ... version of Cockpit,” says David Cronin, CEO of Cognition. “We’re thrilled to finally ...
(Date:5/18/2017)... ... ... Sherley, was notified earlier this year that his company Asymmetrex had been selected ... Silicon Review , he was not surprised as others might be. Sherley says, “I ... Silicon Valley was particularly meaningful. Our selection by The Silicon Review may ...
Breaking Biology Technology: